Clinical Trial Update: The Effect of LINAGLIPTIN on Inflammation, Oxidative Stress and Insulin Resistance in Obese Type 2 Diabetes Subjects [Phase 4]

View source ↗

Summary

A Phase 4 trial assessing the effects of linagliptin on inflammation, oxidative stress, and insulin resistance in obese individuals with Type 2 diabetes has bee…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Linagliptin (linagliptin)

Snippet

Sponsor: University at Buffalo | Conditions: Type 2 Diabetes | Phase 4 | Status: COMPLETED | Results posted: 2023-02-21